Correlation Between Corvus Pharmaceuticals and Histogen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Histogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Histogen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Histogen, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Histogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Histogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Histogen.

Diversification Opportunities for Corvus Pharmaceuticals and Histogen

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Corvus and Histogen is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Histogen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Histogen and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Histogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Histogen has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Histogen go up and down completely randomly.

Pair Corralation between Corvus Pharmaceuticals and Histogen

Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 0.19 times more return on investment than Histogen. However, Corvus Pharmaceuticals is 5.36 times less risky than Histogen. It trades about 0.06 of its potential returns per unit of risk. Histogen is currently generating about -0.3 per unit of risk. If you would invest  864.00  in Corvus Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of  29.00  from holding Corvus Pharmaceuticals or generate 3.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Corvus Pharmaceuticals  vs.  Histogen

 Performance 
       Timeline  
Corvus Pharmaceuticals 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Corvus Pharmaceuticals are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Corvus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Histogen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Histogen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Corvus Pharmaceuticals and Histogen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Corvus Pharmaceuticals and Histogen

The main advantage of trading using opposite Corvus Pharmaceuticals and Histogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Histogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will offset losses from the drop in Histogen's long position.
The idea behind Corvus Pharmaceuticals and Histogen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities